When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
A recent study suggests that the US should standardize breast density reporting and require that all women receive notification.
A recent AMP report offers recommendations to policymakers to prevent problems in future public health emergencies.
Malpractice premium costs are climbing at rates not seen since the turn of the century, according to a new AMA report.
MFCU enforcement activity has rebounded from recent declines but still hasn’t reached pre-pandemic levels, according to a recent OIG report.
With increasing media coverage about problems with genetic non-invasive prenatal screening, the agency warns of risks of false results.
While HHS hasn’t yet officially withdrawn SUNSET, recent indications are that it’s only a matter of time.
Thanks to recent federal enforcement initiatives, prompt response to patient PHI requests should be a growing priority for HIPAA compliance.
This month’s roundup includes the continued court battle between BGI and Illumina, an FCA lawsuit, and the latest version of OSHA’s COVID-19 rule.
Company involved in recent Class 1 recalls of COVID-19 rapid tests now faces further fallout by not refunding customers for faulty tests.